StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) stock

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$9.01−0.11 (-1.21%)

Close on Nov 13, 2026Market cap $1.25BP/E –Yield –

COMPASS Pathways operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

COMPASS Pathways's operating cash flow for the twelve months ending Jun 30, 2026 was -$161.14M. For fiscal 2025 it was -$157.24M. The highest annual figure on record is -$17.81M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$157.24M–
FY2024Dec 31, 2024-$119.19M–
FY2023Dec 31, 2023-$97.38M–
FY2022Dec 31, 2022-$105.45M–
FY2021Dec 31, 2021-$67.75M–
FY2020Dec 31, 2020-$41.38M–
FY2019Dec 31, 2019-$17.81M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$40.31M–
Q1 FY2026Mar 31, 2026-$47.94M–
Q4 FY2025Dec 31, 2025-$37.79M–
Q3 FY2025Sep 30, 2025-$35.11M–
Q2 FY2025Jun 30, 2025-$38.69M–
Q1 FY2025Mar 31, 2025-$45.66M–
Q4 FY2024Dec 31, 2024-$41.76M–
Q3 FY2024Sep 30, 2024-$22.19M–
Q2 FY2024Jun 30, 2024-$34.42M–
Q1 FY2024Mar 31, 2024-$20.83M–
Q4 FY2023Dec 31, 2023-$27.78M–
Q3 FY2023Sep 30, 2023-$17.06M–
Q2 FY2023Jun 30, 2023-$24.81M–
Q1 FY2023Mar 31, 2023-$27.72M–
Q4 FY2022Dec 31, 2022-$45.30M–
Q3 FY2022Sep 30, 2022-$19.02M–
Q2 FY2022Jun 30, 2022-$18.01M–
Q1 FY2022Mar 31, 2022-$23.12M–
Q4 FY2021Dec 31, 2021-$22.37M–
Q3 FY2021Sep 30, 2021-$13.90M–
Q2 FY2021Jun 30, 2021-$17.70M–
Q1 FY2021Mar 31, 2021-$13.78M–
Q4 FY2020Dec 31, 2020-$16.75M–
Q3 FY2020Sep 30, 2020-$13.91M–

More COMPASS Pathways figures

See a number that looks wrong?